Thoracic Surgery: What You Need To Know

Table of Contents

Main Topic

Find Top Surgery Clinical Trials

Choose from over 30,000 active clinical trials.

Conditions and Clinical Trials in Thoracic Diseases

Thoracic diseases encompass conditions affecting the chest region, including disorders of the lungs, heart, and esophagus. Common thoracic diseases include lung cancer, asthma, tuberculosis, and pneumonia.

Clinical trials are conducted to test new treatments for these illnesses, aiming to find better methods for prevention, detection, or treatment. Participation in a clinical trial is voluntary and requires understanding of the study's details.

A clinical trial typically progresses through three phases:

Phase I tests an experimental treatment on a small group of people (20-80) for the first time.
Phase II expands the scope to more participants (100-300).
Phase III involves large groups of people (1,000 - 3,000) to confirm the effectiveness of the drug.

The outcomes of these phases determine whether treatments become standard practice in medicine.

Information about ongoing clinical trials is available through registries like ClinicalTrials.gov. These registries provide details about each phase of the trial, including the risks and benefits associated with participation.

The participation in clinical trials contributes to the advancement of medical knowledge on thoracic diseases, benefiting future patients with similar conditions.